Andrea Natali Selected Research

Andrea Natali Research Topics

Disease

49	Insulin Resistance 04/2024 - 12/2002
31	Type 2 Diabetes Mellitus (MODY) 04/2024 - 06/2004
17	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 03/2005
12	Atherosclerosis 12/2023 - 10/2011
11	Hypertension (High Blood Pressure) 06/2020 - 06/2004
10	Inflammation (Inflammations) 10/2023 - 03/2005
9	Hyperglycemia 01/2022 - 02/2002
8	Glucose Intolerance 04/2024 - 12/2006
8	Obesity 01/2024 - 12/2004
8	Hyperinsulinism (Hyperinsulinemia) 08/2023 - 06/2004
6	Heart Failure 11/2023 - 01/2020
4	Hypertriglyceridemia 04/2024 - 06/2004
4	Body Weight (Weight, Body) 11/2023 - 04/2017
4	Dyslipidemias (Dyslipidemia) 10/2010 - 06/2004
3	Overweight 11/2023 - 04/2006
3	Albuminuria 11/2023 - 11/2019
3	Abdominal Obesity 04/2016 - 06/2004
2	Myocardial Ischemia (Ischemic Heart Diseases) 03/2024 - 10/2017
2	Chronic Renal Insufficiency 11/2023 - 11/2022
2	Neoplasms (Cancer) 10/2023 - 07/2015
2	Carotid Artery Diseases 01/2022 - 01/2022
2	Myocardial Infarction 01/2021 - 04/2010
2	Diabetic Nephropathies (Diabetic Nephropathy) 02/2020 - 11/2019
2	Fatty Liver 01/2020 - 01/2017
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2016 - 12/2007
2	Neutral Lipid Storage Disease with Myopathy 09/2013 - 01/2013
1	Coronary Artery Disease (Coronary Atherosclerosis) 03/2024
1	Pathologic Constriction (Stenosis) 12/2023
1	Renal Insufficiency (Renal Failure) 11/2023
1	Glycosuria 11/2023
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2023
1	Heart Diseases (Heart Disease) 12/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 11/2022
1	Non-alcoholic Fatty Liver Disease 11/2021
1	Atherosclerotic Plaque (Atheroma) 09/2021
1	Ischemic Stroke 01/2021
1	Atrial Fibrillation 01/2021

Drug/Important Bio-Agent (IBA)

49	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 12/2002
33	Insulin (Novolin)FDA Link 04/2024 - 02/2002
13	Biomarkers (Surrogate Marker)IBA 12/2022 - 05/2010
11	LipidsIBA 04/2024 - 12/2002
9	HDL CholesterolIBA 03/2024 - 06/2004
9	Triglycerides (Triacylglycerol)IBA 01/2023 - 04/2007
9	C-PeptideIBA 01/2022 - 12/2006
6	Nonesterified Fatty Acids (NEFA)IBA 04/2024 - 06/2013
5	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2023 - 11/2015
4	Fatty Acids (Saturated Fatty Acids)IBA 04/2024 - 05/2010
4	Peptides (Polypeptides)IBA 12/2023 - 10/2011
4	Proteins (Proteins, Gene)FDA Link 11/2023 - 11/2006
4	Interleukin-6 (Interleukin 6)IBA 10/2023 - 01/2015
4	C-Reactive ProteinIBA 07/2020 - 04/2006
4	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 06/2004
4	CholesterolIBA 01/2018 - 07/2006
3	CarbohydratesIBA 11/2023 - 01/2016
3	CreatinineIBA 11/2023 - 01/2020
3	IncretinsIBA 01/2021 - 12/2006
3	oxidized low density lipoproteinIBA 01/2021 - 04/2007
3	CytokinesIBA 07/2020 - 04/2006
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2012 - 06/2004
2	Oxygen (Dioxygen)IBA 01/2024 - 12/2022
2	Glucagon (Glukagon)FDA Link 11/2023 - 01/2018
2	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2023 - 01/2021
2	prostaglandin-inositol cyclic phosphateIBA 10/2023 - 09/2021
2	AdipokinesIBA 08/2023 - 06/2013
2	Uric Acid (Urate)IBA 12/2022 - 11/2008
2	empagliflozinIBA 12/2022 - 10/2017
2	Sitagliptin Phosphate (Januvia)FDA Link 12/2022 - 10/2017
2	lixisenatideIBA 01/2021 - 01/2020
2	Hormones (Hormone)IBA 01/2021 - 12/2006
2	AdiponectinIBA 01/2021 - 12/2013
2	ApolipoproteinsIBA 01/2021 - 12/2013
2	Apolipoprotein C-IIIIBA 01/2021 - 01/2018
2	Clostridium perfringens epsilon-toxinIBA 01/2020 - 01/2020
2	InterleukinsIBA 10/2019 - 04/2006
2	Matrix Metalloproteinases (MMPs)IBA 10/2019 - 07/2015
2	Amino Acids FDA Link 09/2019 - 05/2010
2	LigandsIBA 10/2018 - 11/2006
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2018 - 10/2011
2	Lipase (Acid Lipase)FDA Link 09/2013 - 01/2013
2	Acetylcholine (Acetylcholine Chloride)FDA Link 04/2006 - 06/2004
2	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 04/2006 - 06/2004
1	Collagen Type III (Type III Collagen)IBA 12/2023
1	Complement C3 (C3 Complement)IBA 12/2023
1	KetonesIBA 11/2023
1	CanagliflozinIBA 11/2023
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2023
1	LeptinIBA 08/2023
1	Protons (Proton)IBA 01/2023
1	Lipoproteins (Lipoprotein)IBA 01/2023
1	Sodium-Glucose Transport ProteinsIBA 12/2022
1	NAD (NADH)IBA 11/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	FollistatinIBA 11/2021
1	CD40 Ligand (CD40L)IBA 09/2021
1	Pioglitazone (Actos)FDA Link 01/2021
1	2,4-thiazolidinedione (thiazolidinedione)IBA 01/2021
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021
1	DiureticsIBA 01/2021

Therapy/Procedure

3	Therapeutics 10/2023 - 12/2002
2	Glycemic Control 04/2006 - 06/2004